Derek Lowe writes about dry pipelines in his blog "In the Pipeline".
His points are, as always, well made.
The "comments" are also thought provoking.
A "cynical academic" writes:
"Big Pharma companies are slowly (or quickly?) turning into Big Marketing companies. They'll do a bit of their own research and discovery, but it would be interesting to take bets on which FIPCO (fully integrated Pharma Co) first admits that it's not doing research any longer and will just license other discoveries for flogging to docs.
Ooops, J&J beat us to it in some ways, although some would argue they were never really a FIPCO as much as a shampoo and baby-food company...
Pipelines are shrinking b/c the internal bars are higher as Derek points out and also b/c our short-term company mentality chases existing profits (humping current products) at the expense of taking chances."
Oooh! The truth can hurt! Look at Big Pharma gobbling up the biotechs for their research compounds.
No comments:
Post a Comment